Literature DB >> 4816332

Effects of chronic pretreatment with small doses of reserpine upon adrenergic nerve function.

M J Antonaccio, C B Smith.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4816332

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


× No keyword cloud information.
  7 in total

1.  An electrophysiological analysis of the effects of reserpine on adrenergic neuromuscular transmission.

Authors:  M R Bennett; J Middleton
Journal:  Br J Pharmacol       Date:  1975-09       Impact factor: 8.739

2.  The effect of pretreatment with reserpine on the diastolic potential of guinea-pig atrial cells.

Authors:  D A Taylor; D P Westfall; S De Moraes; W W Fleming
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1976       Impact factor: 3.000

3.  Evidence for co-transmitter role of neuropeptide Y in the pig spleen.

Authors:  J M Lundberg; A Rudehill; A Sollevi; B Hamberger
Journal:  Br J Pharmacol       Date:  1989-03       Impact factor: 8.739

4.  The influence of hormonal and neuronal factors on rat heart adrenoceptors.

Authors:  G Kunos; L Mucci; S O'Regan
Journal:  Br J Pharmacol       Date:  1980       Impact factor: 8.739

5.  Transient supersensitivity to alpha-adrenoceptor agonists, and distinct hyper-reactivity to vasopressin and angiotensin II after denervation of rat tail artery.

Authors:  Diana Tripovic; Svetlana Pianova; Elspeth M McLachlan; James A Brock
Journal:  Br J Pharmacol       Date:  2009-12-04       Impact factor: 8.739

6.  Effects of tetraethylammonium on the action potential duration as modified by catecholamine-releasing action in guinea-pig papillary muscles.

Authors:  M Kojima; T Ban
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1986-09       Impact factor: 3.000

7.  Energy utilization and pyruvate as determinants of pyruvate dehydrogenase in norepinephrine-stimulated heart.

Authors:  R Bünger; B Permanetter; S Yaffe
Journal:  Pflugers Arch       Date:  1983-05       Impact factor: 3.657

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.